Back to results
US 12,702,659 B2Granted
Rifaximin liquid formulations
AssigneeBausch Health Ireland Limited
InventorsArturo J. Angel, Kasturi R. Pawar, Radhakrishnan S. Pillai
Life of this patent
Estimating the term…
Abstract
Provided herein are pharmaceutical compositions which enhance the intestinal levels of soluble rifaximin, formulations comprising said compositions, and their use in treating one or more bowel related disorders.
Claims21
A pharmaceutically acceptable composition comprising rifaximin, a hydrogenated castor oil in an amount ranging from about 25% to about 65% by weight of the composition, and at least one additional solubilizing excipient comprising a combination of castor oil, glyceryl caprylate, and polysorbate 80.
Dependencies are inferred from the claim text.